PROS1 Heerlen polymorphism is associated with increased free plasma tissue factor pathway inhibitor levels

Rene Mulder; Min Ki ten Kate; Hanneke C. Kluin-Nelemans; Andre B. Mulder

doi:10.1160/TH11-08-0549

PROS1 Heerlen polymorphism is associated with increased free plasma tissue factor pathway inhibitor levels

Rene Mulder^*, Min Ki ten Kate, Hanneke C. Kluin-Nelemans, Andre B. Mulder

^*Corresponding author for this work

Faculty of Medical Sciences/UMCG

Research output: Contribution to journal › Letter (Research letter) › Academic › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	594-596
Number of pages	3
Journal	Thrombosis and Haemostasis
Volume	107
Issue number	3
DOIs	https://doi.org/10.1160/TH11-08-0549
Publication status	Published - Mar-2012

Keywords

PROTEIN-S DEFICIENCY
RECURRENT VENOUS THROMBOEMBOLISM
COAGULATION INHIBITOR
RISK
THROMBOSIS
INACTIVATION
HEREDITARY
MUTATION

Access to Document

10.1160/TH11-08-0549

Handle.net

Persistent link

Cite this

@article{a0d11740033247b9a343c59008c56022,

title = "PROS1 Heerlen polymorphism is associated with increased free plasma tissue factor pathway inhibitor levels",

keywords = "PROTEIN-S DEFICIENCY, RECURRENT VENOUS THROMBOEMBOLISM, COAGULATION INHIBITOR, RISK, THROMBOSIS, INACTIVATION, HEREDITARY, MUTATION",

author = "Rene Mulder and \{ten Kate\}, \{Min Ki\} and Kluin-Nelemans, \{Hanneke C.\} and Mulder, \{Andre B.\}",

year = "2012",

month = mar,

doi = "10.1160/TH11-08-0549",

language = "English",

volume = "107",

pages = "594--596",

journal = "Thrombosis and Haemostasis",

issn = "0340-6245",

publisher = "GEORG THIEME VERLAG KG",

number = "3",

}

TY - JOUR

T1 - PROS1 Heerlen polymorphism is associated with increased free plasma tissue factor pathway inhibitor levels

AU - Mulder, Rene

AU - ten Kate, Min Ki

AU - Kluin-Nelemans, Hanneke C.

AU - Mulder, Andre B.

PY - 2012/3

Y1 - 2012/3

KW - PROTEIN-S DEFICIENCY

KW - RECURRENT VENOUS THROMBOEMBOLISM

KW - COAGULATION INHIBITOR

KW - RISK

KW - THROMBOSIS

KW - INACTIVATION

KW - HEREDITARY

KW - MUTATION

U2 - 10.1160/TH11-08-0549

DO - 10.1160/TH11-08-0549

M3 - Letter (Research letter)

SN - 0340-6245

VL - 107

SP - 594

EP - 596

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

IS - 3

ER -